Financial statements Alfamedic
Balance sheet data of ALFAMEDIC
|
Year
|
2020
|
2021
|
|---|---|---|
| Total assets | 364 956,61 | 447 324,62 |
| A. Fixed assets | 218 446,53 | 150 536,97 |
| B. Current assets | 146 510,08 | 296 787,65 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 364 956,61 | 447 324,62 |
| A. Equity | -300 971,97 | -247 895,44 |
| B. Liabilities and provisions for liabilities | 665 928,58 | 695 220,06 |
| I. Long-term liabilities | 376 600,00 | 433 250,00 |
| II. Short-term liabilities | 289 328,58 | 261 970,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.